Therapeutic antibodies are prone to degradation via a variety of pathways during each stage of the manufacturing process. Hence, a low-cost, rapid, and broadly applicable tool that is able to identify ...

In 1990, Koderisch et al. were the first to report the presence of 'false-positive' ANCAs by indirect immunofluorescence and anti-myeloperoxidase antibodies by enzyme-linked immunosorbent assay in ...

A comparison is made of the quantitative detection of a labeled antibody by surface-enhanced resonance Raman scattering (SERRS) and by fluorescence using the same instrument with the same laser ...